Page 2 - Personalized Diagnostics News Today

A global leader in developing artificial intelligence to improve outcomes for people with cancer and other diseases, Anant Madabhushi joins Emory in July as part of the university’s growing research community focused on advancing AI to serve humanity.

Building on its successes in applying artificial intelligence (AI) to medical imaging to enhance treatment of other diseases, a Case Western Reserve University-led team next will test its approach with rectal cancer patients.

Case Western Reserve-led team to test artificial intelligence medical imaging to determine which rectal cancer patients need surgery-or can avoid it

 

Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have used artificial intelligence (A

Researchers identify set of patterns from CT scans to help predict patient’s response to chemotherapy Researchers at the Center for Computational

Researchers at the Center for Computational Imaging and Personalized Diagnostics at Case Western Reserve University have used artificial intelligence (AI) to identify patterns on computed tomography (CT) scans that offer new promise for treating patients with small cell lung cancer.

May 4, 2021 $275,000 awarded to ASU, community entrepreneurship ventures A venture founded by two Arizona State University alums that makes gear-storage racks out of recycled plastic has won a $10,000 investment. Sean Dicke and Nicholas Raccosta won the money for their company, Strax Gear, in the Retail Devils funding track during the Demo Day pitch competition on April 30. Strax Gear makes a $79.99 Infinity Rack, which holds up to 40 pounds of gear, such as bikes or snowboa...

CWRU, University Hospitals are part of a $3 million grant project on lung cancer, immunotherapy CWRU, University Hospitals are part of a $3 million grant project on lung cancer, immunotherapy Anant Madabhushi Researchers from Case Western Reserve University and University Hospitals are part of a $3 million National Cancer Institute grant to develop artificial intelligence tools to help predict which lung cancer patients would respond to immunotherapy. The team also includes researchers from New...

Artificial Intelligence Identifies Lung Cancer Patients at Risk of Harm Caused by Immunotherapy February 9, 2021 In a subset of patients diagnosed with non-small cell lung cancer (NSCLC), immunotherapy paradoxically exacerbates tumor growth and significantly shortens survival. Currently there are no clinically validated biomarkers that can identify patients at risk of this paradoxical response called “hyperprogression.” Using artificial intelligence (AI) analysis of simple tissue scans, res...